Our Board Advisors
Our Board Advisors serve in a non-governing, non-voting capacity and play a critical role in strengthening Sickle Cell Prodigy's impact through strategic insight, subject-matter expertise, and informed guidance.
Representing regions around the world where cell and gene therapy is available, our advisors also serve as primary points of contact for patients and care partners living outside the United States, providing localized support, trusted resources, and connections to clinicians and treatment centers as individuals navigate transformative therapies.
Board Advisor (Canada) - Survivorship & Patient Experience
Zainab Garba-Sani
Board Advisor (United Kingdom) - Policy, Advocacy & Systems Change
Luce Kuseke Sona
Board Advisor (France) - Survivorship & Patient Experience
Dr. Charity Oyedeji
Board Advisor - Clinical Research & Aging with SCD
Dr. Akshay Sharma
Board Advisor - Clinical & Research Insight
Dr. Stacia Martin Peron
Board Advisor - Clinical Research & Psychotherapy
Hasmin Ramirez-Villegas, MPH
Board Advisor - Clinical Research
Ade Adeyokunnu
Board Advisor - Partnership & Innovation
TaLana Hughes
Board Advisor - Survivorship & Caregiver Experience
Chris Lundy
Board Advisor - Survivorship & Patient Experience
Ambria Williams
Board Advisor - Ethics, Equity & Community Trust
Fisayo Ogundele, PharmD
Board Advisor - Patient Experience & Community Trust